Sperm Count

If you are thinking about having children now or someday, this is the single most informative number you can put on a lab report about your reproductive biology. It tells you whether your body is making enough sperm to conceive naturally, and whether something is interfering with that process.

The number also carries information that reaches beyond fertility. Men with lower counts have higher rates of hypogonadism, metabolic problems, and earlier mortality in large cohort studies, which means this test can flag concerns a standard physical or blood panel will not pick up.

What This Test Actually Measures

Sperm count is the total number of sperm cells in an ejaculate, usually reported as both a concentration (millions per milliliter) and a total count (millions in the full sample). It is not a hormone or a protein. It is a direct census of the cells your testicles have produced and your reproductive tract has delivered.

Sperm are made in the testicles in a process called spermatogenesis, mature in a coiled tube behind each testicle (the epididymis), and mix with fluid from the prostate and other glands at ejaculation. A count reflects how efficiently that entire pipeline is working over the prior two to three months, since that is roughly how long it takes a sperm cell to develop.

Fertility and the Chance of Pregnancy

Sperm count has a direct, measurable relationship with how likely you are to conceive each month. The relationship is not linear all the way up, but at the low end it matters a great deal.

In a population study of 430 couples trying for a first pregnancy, the chance of conception rose steadily with sperm concentration up to about 40 million per milliliter. Above that level, additional sperm did not further raise the monthly pregnancy rate. Below it, the per-cycle odds dropped meaningfully. Normal shape (morphology) added predictive value, while semen volume and motility contributed less.

This is why a single low result is not automatically a fertility verdict. It is a probability shift, and the size of the shift depends on how far below the threshold you are.

The Bigger Picture: Sperm Count and Long-Term Health

This is the finding most men do not know about and the reason this test belongs in a longevity workup, not just a fertility one.

In a study of 78,284 men followed for up to 50 years, men with higher semen quality had a lower risk of all-cause mortality, regardless of education or diseases recorded at the time of testing. A separate U.S. cohort of 11,935 men found that those with impaired semen parameters had higher mortality than men with normal semen. In a Danish cohort of 4,712 men, lower sperm concentrations were tied to a higher risk of later hospitalization for cardiovascular disease and diabetes.

A study of 5,177 men at an Italian andrology center showed that low sperm counts traveled together with hypogonadism, worse metabolic profiles, more metabolic syndrome, and lower bone density. A separate analysis of 48,866 men found that subfertility from semen samples was linked to a higher risk of testicular cancer.

Reconciling the Counterintuitive Finding

It sounds strange that a fertility marker would predict heart disease or early death. The explanation is simpler than it looks. Sperm production is metabolically demanding, hormonally regulated, and sensitive to inflammation, cellular damage from unstable molecules, and toxins. When something in the body's wider machinery is off, the testicles are often the first organ to show it. A low count is not the disease. It is the smoke detector.

What Drives Low Counts at the Population Level

Counts are not just personal numbers. They are shifting across generations. A meta-analysis of 223 studies covering samples collected between 1973 and 2018 found about a 52 percent decline in sperm concentration and about a 62 percent decline in total sperm count among men not selected for fertility, with the decline accelerating after 2000. A separate review of data from 1980 to 2015 reported about a 57 percent drop in mean sperm concentration worldwide. A fertility center in China analyzing 49,819 men between 2015 and 2021 saw declines in both semen volume and count over just seven years.

The strongest identified contributors in human studies include obesity (which raises the odds of oligozoospermia and azoospermia), smoking (which lowered sperm count by about 9.7 million per milliliter in a meta-analysis of 5,865 men), and acute illness or inflammation, including COVID-19, where 39 percent of patients in one study had oligozoospermia.

Reference Ranges

Sperm count is a Tier 2 marker in clinical maturity. There are widely cited reference limits from the World Health Organization, but counts also vary substantially within the same person from week to week and across labs. These numbers are best used as orientation, not as pass/fail lines.

Source: WHO reference values for human semen characteristics (Cooper et al., 2009); WHO laboratory manual sixth edition; Levine et al. meta-analysis.

What this means for you: the per-cycle pregnancy chance climbs steadily up to about 40 million per milliliter, so a result in the lower end of normal is not the same as a result in the higher end. Compare your number within the same lab over time rather than against a single threshold.

Tracking Your Trend

A single sperm count is the noisiest snapshot in fertility testing. The same man, sampled twice a few weeks apart, can produce dramatically different numbers. WHO guidance has historically recommended at least two analyses for diagnosis, and a real-world study of 1,358 men found that 60 percent of men whose first test fell below WHO limits had a second test that did not match the first.

For most men focused on prevention or family planning, the right cadence is a baseline test now, a repeat in three to six months if you are changing lifestyle factors or beginning treatment, and at least annual monitoring after that. Trends are far more meaningful than any single value.

When Results Can Be Misleading

Several factors can distort a single result and lead to the wrong conclusion.

• Recent fever or acute illness: a fever in the prior three months can substantially lower sperm count and worsen morphology, with case reports showing temporary impairment that resolves over the following weeks. Mild or asymptomatic COVID-19 has been shown to reduce semen parameters in the short term.
• Abstinence time: abstinence periods longer than four to seven days can raise concentration while sometimes lowering motility. Inconsistent abstinence between samples is one of the largest sources of variability.
• Collection errors: an incomplete sample, leaking some ejaculate, or letting the sample sit too long before analysis can produce a misleadingly low number.
• Recent medications: drugs such as certain antidepressants, finasteride, ketoconazole, methotrexate, and some chemotherapy agents can suppress sperm production without causing permanent testicular disease, and the effect is usually reversible after stopping.

What an Abnormal Result Should Lead You To Do

If your count comes back low, the most useful next step is to confirm the finding with a second analysis after a consistent abstinence period of two to seven days, ideally at the same lab. If both samples are low, the workup expands.

A reasonable companion workup includes hormone testing (FSH, LH, total testosterone, estradiol, prolactin), which can distinguish testicular failure from a pituitary or endocrine cause. In a study of 11,929 Chinese men, FSH was an effective marker for distinguishing oligospermia from non-obstructive azoospermia. For severe oligozoospermia or azoospermia, genetic testing (karyotype and Y-chromosome microdeletion) is warranted, since clinically relevant Y deletions cluster at counts below 1 million per milliliter.

In men with unexplained infertility, recurrent pregnancy loss, varicocele, or advanced paternal age, sperm DNA fragmentation testing provides information that a count cannot. A meta-analysis found that a DNA fragmentation threshold of about 20 percent distinguished fertile from infertile men with about 79 percent sensitivity and 86 percent specificity. If the pattern points to a treatable cause (varicocele, hormone deficiency, infection), a reproductive urologist or andrologist can match the workup to the suspected mechanism.